logo
Plus   Neg
Share
Email

Sanofi Q1 Profit Rises; Backs 2019 Business EPS Outlook - Quick Facts

French drug giant Sanofi SA (SNYNF,SNY) reported Friday that its net income attributable to equity holders for the first quarter of 2019 rose to 1.14 billion euros from last year's 1.02 billion euros, with earnings per share rising to 0.91 euros from 0.81 euros in the prior year.

Net income, excluding the held for exchange Animal Health business, increased to 1.15 billion euros from 1.05 billion euros in the prior year. Earnings per share, excluding the held for exchange AnimalHealth business, were 0.91 euros, up from 0.81 euros in the previous year.

First-quarter business net income increased 10.5 percent to 1.77 billion euros, and increased 9 percent at CER. Business earnings per share rose 10.9 percent to 1.42 euros on a reported basis, and increased 9.4 percent at CER.

Quarterly sales increased 6.2 percent to 8.39 billion euros from 7.90 billion euros in the year-ago quarter. At CER, company sales grew 4.2 percent.

Exchange rate movements had a positive effect of 2.0 percentage points mainly driven by the U.S. dollar, which largely offset the negative impact from the Argentine Peso, Turkish Lira, Brazilian Real and Russian Ruble.

Looking ahead to fiscal 2019, Sanofi said it continues to expect business earnings per share to grow between 3 percent and 5 percent at CER, barring unforeseen major adverse events. Applying the average April 2019 exchange rates, the company estimates the currency impact on 2019 business earnings per share to be around 2 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Tesla said it will produce ventilators at its Gigafactory in Buffalo, New York to support the city's hospitals amid the coronavirus pandemic. New York is the worst affected state in the U.S. Last Saturday, Musk tweeted that he "had a long engineering discussion with Medtronic about state-of-the-art ventilators. Luxury fashion house Ralph Lauren will donate $10 million to help fight the coronavirus pandemic and manufacture face masks as well as medical gowns in the U.S. The company's charity arm, the Ralph Lauren Corporate Foundation, said in a statement that it is committing $10 million towards the global response to the COVID-19 pandemic. General Motors Co. is delaying work on new vehicle models and is cutting pay for its executives as part of efforts to conserve cash amid the coronavirus or Covid-19 pandemic. The automotive giant also extended the shutdown of North American plants indefinitely. Multiple reports cited an internal memo that salaried workforce will have 20 percent of pay deferred starting April 1.
Follow RTT
>